Hetlioz.com - HETLIOZ® (tasimelteon) is the first and only FDA-approved …

Provided by Alexa ranking, hetlioz.com has ranked N/A in N/A and 1,230,856 on the world. hetlioz.com reaches roughly 2,540 users per day and delivers about 76,212 users each month. The domain hetlioz.com uses a Commercial suffix and it's server(s) are located in N/A with the IP number 54.234.227.50 and it is a .com domain.

WEBHETLIOZ ® is the first and only medication that's been proven to treat people with Non-24 and nighttime sleep disturbances in SMS. Learn More. HETLIOZ Solutions ™ can help with questions about insurance coverage and prescription delivery, as well as provide educational resources. Learn More. Sign up for information about HETLIOZ ®.

List of domain same IP 54.234.227.50

Keywords on this domain

hetlioz

hetlioz medication

hetlioz generic

hetlioz solutions

hetlioz cost

hetlioz sales

hetlioz lq

hetlioz drug company

hetlioz tasimelteon

hetlioz fda

hetlioz prescription form

hetlioz label

hetlioz 20 mg

hetlioz tasimelteon specialty pharmacy

Search Results related to hetlioz.com on Search Engine

  • HETLIOZ® (tasimelteon) is the first and only FDA-approved …

    hetlioz.com

    https://www.hetlioz.com/

    WEBHETLIOZ ® is the first and only medication that's been proven to treat people with Non-24 and nighttime sleep disturbances in SMS. Learn More. HETLIOZ Solutions ™ can help with questions about insurance coverage and prescription delivery, as well as provide educational resources. Learn More. Sign up for information about HETLIOZ ®.

    DA: 38 PA: 44 MOZ Rank: 23

  • Hetlioz: Side Effects, Dosage & Uses - Drugs.com

    drugs.com

    https://www.drugs.com/hetlioz.html

    WEBJun 26, 2023 · Hetlioz is used to treat non-24-hour sleep-wake disorder in adults. Hetlioz is also used to treat nighttime sleep problems in people with a genetic disorder called Smith-Magenis Syndrome (SMS). The capsule form of Hetlioz is for people with SMS who are at least 16 years old.

    DA: 10 PA: 3 MOZ Rank: 52

  • HETLIOZ® (tasimelteon) is the first and only FDA-approved …

    hetlioz.com

    https://hetlioz.com/abouthetlioz

    WEBHETLIOZ ® is a melatonin receptor agonist that is FDA approved for both Non-24-Hour Sleep-Wake Disorder (a serious, chronic circadian rhythm disorder) and nighttime sleep disturbances in Smith-Magenis Syndrome (SMS) in patients 16 years of age and older.

    DA: 73 PA: 12 MOZ Rank: 15

  • Tasimelteon - Wikipedia

    wikipedia.org

    https://en.wikipedia.org/wiki/Tasimelteon

    WEBTasimelteon, sold under the brand name Hetlioz, is a medication approved by the U.S. Food and Drug Administration (FDA) in January 2014, for the treatment of non-24-hour sleep–wake disorder (also called non-24, N24 and N24HSWD).

    DA: 96 PA: 12 MOZ Rank: 58

  • Hetlioz (tasimelteon): Uses, Side Effects, Dosage & Reviews

    goodrx.com

    https://www.goodrx.com/hetlioz/what-is

    WEBNov 16, 2021 · Hetlioz (tasimelteon) is used to help people who are totally blind with non-24-hour sleep-wake disorder (non-24) maintain regular sleep cycles. Hetlioz (tasimelteon) is also used to treat sleep disturbances in patients with Smith-Magenis Syndrome (SMS). It's the first and currently only FDA-approved treatment for people with non-24 and SMS.

    DA: 21 PA: 15 MOZ Rank: 32

  • HETLIOZ (tasimelteon) Non-24-Hour Sleep-Wake Disorder …

    hetliozpro.com

    https://www.hetliozpro.com/

    WEBHETLIOZ (tasimelteon) is the first & only treatment for Non-24-Hour Sleep-Wake Disorder, a chronic circadian rhythm disorder. See Full Important Safety Information here.

    DA: 8 PA: 69 MOZ Rank: 14

  • Hetlioz Oral: Uses, Side Effects, Interactions, Pictures ... - WebMD

    webmd.com

    https://www.webmd.com/drugs/2/drug-165884/hetlioz-oral/details

    WEBTasimelteon is used to treat certain sleep disorders (non-24-hour sleep -wake disorder, sleep disturbances in Smith-Magenis Syndrome). It works like a natural substance called melatonin that your...

    DA: 24 PA: 32 MOZ Rank: 51

  • Hetlioz | European Medicines Agency

    europa.eu

    https://www.ema.europa.eu/en/medicines/human/EPAR/hetlioz

    WEBWhat is Hetlioz and what is it used for? How is Hetlioz used? How does Hetlioz work? What benefits of Hetlioz have been shown in studies? What are the risks associated with Hetlioz? Why is Hetlioz approved? What measures are being taken to ensure the safe and effective use of Hetlioz? Other information about Hetlioz.

    DA: 23 PA: 61 MOZ Rank: 58

  • u HETLIOZ (tasimelteon) capsules, for oral use Initial U.S.

    fda.gov

    https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/205677s006lbl.pdf

    WEBHETLIOZ is a melatonin receptor agonist indicated for the treatment of Non. 24-Hour Sleep-Wake Disorder (Non-24) (1) ______________ DOSAGE AND ADMINISTRATION...

    DA: 1 PA: 7 MOZ Rank: 65

  • Hetlioz (Tasimelteon Capsules): Side Effects, Uses, Dosage

    rxlist.com

    https://www.rxlist.com/hetlioz-drug.htm

    WEBMar 8, 2023 · Drug Summary. What Is Hetlioz? Hetlioz (tasimelteon) is a melatonin receptor agonist used for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24). What Are Side Effects of Hetlioz? Hetlioz may cause serious side effects including: hives, difficulty breathing, swelling of your face, lips, tongue, or throat, and.

    DA: 51 PA: 76 MOZ Rank: 83

Alexa Rank

Alexa

GLOBAL RANK

1,230,856
Alexa

Alexa Reach

0.0001121436
Alexa

Page length

N/A
Alexa

Alexa Rank Country N/A

N/A
Alexa

Daily Unique Visitors

2,540
Alexa

Monthly Unique Visitors

76,212

Vistor via Country

Country lang
Country code
Total visitor

United States

US

16,302

Indonesia

ID

12,750

Taiwan

TW

4,146

United Kingdom

GB

3,681

Brazil

BR

3,330

Nigeria

NG

2,911

Egypt

EG

2,446

Hong Kong

HK

2,309

Canada

CA

2,309

Australia

AU

2,012

Philippines

PH

1,440

India

IN

1,402

Malaysia

MY

1,379

Spain

ES

1,143

Germany

DE

1,113

Mexico

MX

1,067

France

FR

1,006

Italy

IT

930

Turkey

TR

854

Iraq

IQ

777

Thailand

TH

762

Netherlands

NL

732

Israel

IL

724

Cambodia

km

602

Algeria

DZ

465

Ireland

IE

419

Romania

RO

404

Jordan

JO

373

Poland

PL

358

Ghana

GH

343

Argentina

AR

328

South Africa

ZA

297

Belgium

BE

267

Czechia

CZ

244

Ukraine

UA

229

Japan

JA

229

Morocco

MA

221

South Korea

KO

213

Lebanon

LB

206

Saudi Arabia

SA

198

Austria

AT

191

Hungary

HU

183

Sweden

SE

175

Singapore

SG

168

Pakistan

PK

160

Bangladesh

BD

152

Denmark

DK

145

Greece

GR

137

Alexa Traffic Graph

Alexa daily traffic trend graph
Alexa Statistics Graph for hetlioz.com
Alexa daily pageviews (percent) graph
Alexa Statistics Graph for www.nahklick.de
Alexa daily pageviews per user graph
Alexa Statistics Graph for hetlioz.com
Alexa time on site (in minutes) graph
Alexa Statistics Graph for www.nahklick.de
Alexa bounce rate (percent) graph
Alexa Statistics Graph for hetlioz.com
Alexa search visits graph
Alexa Statistics Graph for hetlioz.com

SEOquake Zone

Title Tips
Description Tips
Keywords Tips
Viewport Tips
Icon
UTF-8

Mini site formation by Alexa Rank

MOZ Rank

DA
51

PA
76

MOZ Rank
83

DNS Record

Host Type Class TTL Extra
hetlioz.com A IN 60 Ip: 54.234.227.50
hetlioz.com A IN 60 Ip: 50.16.199.221
hetlioz.com NS IN 3600 Target: ns-1363.awsdns-42.org
hetlioz.com NS IN 3600 Target: ns-1827.awsdns-36.co.uk
hetlioz.com NS IN 3600 Target: ns-35.awsdns-04.com
hetlioz.com NS IN 3600 Target: ns-982.awsdns-58.net
hetlioz.com SOA IN 900 Mname: ns-1363.awsdns-42.org
Rname: awsdns-hostmaster.amazon.com
Serial: 1
Refresh: 7200
Retry: 900
Expire: 1209600
Minimum-ttl: 86400
hetlioz.com TXT IN 300 Txt: google-site-verification=pPc4Yn2p8AwTzbywjjUHpuQIwfrxqh_pnoFKy7EEE9A
Entries_0: google-site-verification=pPc4Yn2p8AwTzbywjjUHpuQIwfrxqh_pnoFKy7EEE9A
hetlioz.com TXT IN 300 Txt: v=spf1 ip4:162.209.31.201 include:spf.m.appature.com include:spf.mandrillapp.com ~all
Entries_0: v=spf1 ip4:162.209.31.201 include:spf.m.appature.com include:spf.mandrillapp.com ~all

Hosting and Whois Zone

IP 50.16.199.221
Domain infomation Domain Name: HETLIOZ.COM
Registry Domain ID: 1822719353_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.markmonitor.com
Registrar URL: http://www.markmonitor.com
Updated Date: 2023-07-19T09:16:06Z
Creation Date: 2013-08-20T21:06:35Z
Registry Expiry Date: 2025-08-20T21:06:35Z
Registrar: MarkMonitor Inc.
Registrar IANA ID: 292
Registrar Abuse Contact Email: [email protected]
Registrar Abuse Contact Phone: +1.2086851750
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS-1363.AWSDNS-42.ORG
Name Server: NS-1827.AWSDNS-36.CO.UK
Name Server: NS-35.AWSDNS-04.COM
Name Server: NS-982.AWSDNS-58.NET
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2024-04-19T01:32:07Z <<<

For more information on Whois status codes, please visit https://icann.org/epp

NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.

TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.

The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.